Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report

1. Breslau, N, Lipton, RB, Stewart, WF, et al. Comorbidity of migraine and depression: investigating potential etiology and prognosis. Neurology. 2003;60:1308-1312.
Google Scholar | Crossref | Medline | ISI2. Jelinski, SE, Magnusson, JE, Becker, WJ, CHORD Study Group. Factors associated with depression in patients referred to headache specialists. Neurology. 2007;68(7):489-495.
Google Scholar | Crossref | Medline3. Kennedy, SH, Lam, RW, McIntyre, RS, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Canadian J Psychiatry. 2016;61(9):540-560.
Google Scholar | SAGE Journals | ISI4. Cooke, LJ, Becker, WJ. Migraine prevalence, treatment and impact: the Canadian women and migraine study. Can J Neurol Sci. 2010;37:580-587.
Google Scholar | Crossref | Medline | ISI5. Worthington, I, Pringsheim, T, Gawel, MJ, et al. Canadian headache society guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013;40(S3):S1-S3.
Google Scholar | Crossref | Medline6. Pringsheim, T, Davenport, WJ, Mackie, G, et al. Canadian headache society guideline for migraine prophylaxis. Can J Neuro Sci. 2012;39(2 Suppl 2):S1.
Google Scholar | Medline | ISI7. Goren, JL, Wiseman, CN. Can combining triptans with SSRIs or SNRIs cause serotonin syndrome? Curr Psychiatry Rep. 2012;11:E1-E2.
Google Scholar8. Rolan, PE . Drug interactions with triptans: which are clinically significant? CNS Drugs. 2012;26(11):949-957.
Google Scholar | Crossref | Medline9. Evans, RW . The FDA alert on serotonin syndrome with comorbid use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. Medscape J Med. 2007;9(3):48.
Google Scholar10. Naranjo, CA, Busto, U, Sellers, EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
Google Scholar | Crossref | Medline | ISI11. LaPorta, LD . Recurrent depression after sumatriptan administration for treatment of migraine. J Clin Psychopharmacol. 1995;15(1):81-82.
Google Scholar | Crossref | Medline12. Ostermann, K, Juckel, G, Roser, P. Possible association of severe major depression with acute cessation of long‐term excessive triptan use. J Clin Pharm Ther. 2013;38(1):77-79.
Google Scholar | Crossref | Medline13. Adis Medical Writers . Consider the risk of potential drug interactions when co-prescribing triptans with other medications. Drugs Ther Perspect. 2013;29(5):151-154.
Google Scholar | Crossref14. Sclar, DA, Robison, LM, Castillo, LV, et al. Concomitant use of triptan, and SSRI or SNRI after the US food and drug administration alert on serotonin syndrome. Headache. 2012;52(2):198-203.
Google Scholar | Crossref | Medline | ISI15. Foong, A, Grindrod, KA, Patel, T, et al. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician. 2018;64(10):720-777.
Google Scholar | Medline16. Foong, A, Patel, T, Kellar, J, et al. The scoop on serotonin syndrome. Can Pharm J 2018; 151(4): 233-239.
Google Scholar | SAGE Journals17. Gillman, PK . Triptans, serotonin agonists and serotonin syndrome (serotonin toxicity): a review. Headache. 2010;50(2):264-272.
Google Scholar | Crossref | Medline18. National Health Services . Triptans and SSRI or SNRI antidepressant – is there an interaction? [internet]. Pembroke Place, Liverpool: National Health Services; 2018.
Google Scholar19. Stahl, SM . Stahl’s Essential Psychopharmacology: Neuroscientific Basis and Practical Application. 4th ed. Cambridge: Cambridge University Press; 2013.
Google Scholar20. Millson, D, Frischer, M, Croft, P, Goadsby, P. Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia. 2000;20(8):732-777.
Google Scholar | SAGE Journals | ISI21. Hagan, CE, McDevitt, RA, Liu, Y, Furay, AR, Neumaier, JF. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes. Synapse. 2012;66(12):1024-1034.
Google Scholar | Crossref | Medline22. Montañez, S, Munn, JL, Owens, WA, Horton, RE, Daws, LC. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice. Neurochem Int. 2014;73:127-131.
Google Scholar | Crossref | Medline23. Ferrari, MD, Roon, KI, Lipton, RB, Goadsby, PJ. Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment. a meta-analysis of 53 trials. Lancet 2001;358:1668-1675.
Google Scholar | Crossref | Medline | ISI24. Dodick, DW, Martin, V. Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. Cephalalgia. 2004;24(6):417-424.
Google Scholar | SAGE Journals | ISI25. Modgill, G, Jette, N, Wang, L, et al. A population-based longitudinal community study of major depression and migraine. Headache. 2012;52:422-432.
Google Scholar | Crossref | Medline | ISI26. Baskin, SM, Smitherman, TA. Migraine and psychiatric disorders: comorbidities, mechanisms, and clinical applications. Neurol Sci. 2009;30(S1):61-65.
Google Scholar | Crossref27. Imitrex (sumatriptan) Tablets . Prescribing information. GlaxoSmithKline. https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Imitrex_Tablets/pdf/IMITREX-TABLETS-PI-PIL.PDF (accessed September 15, 2021).
Google Scholar

留言 (0)

沒有登入
gif